22 08 26 last day warrents

Last day of trading in warrants of series TO 1 is 30 August 2022

Tuesday, 30 August 2022, is the last day of trading in CS MEDICA A/S’s (“CS MEDICA” or the “Company”) warrants of series TO 1 on Spotlight Stock Market. The warrants were issued in connection with the Company’s issue of units that took place in September 2021. Each (1) warrant of series TO 1 entitles the holder to subscribe for one (1) new share in CS MEDICA. Last day to exercise the warrants of series TO 1 and subscribe for shares is 1 September 2022. Note that the banks/nominees need to be notified well in advance before the exercise period ends.

Each (1) warrant of series TO 1 entitles the holder to subscribe for one (1) new share in CS MEDICA at a price of DKK 9.30 per share. Warrants of series TO 1 that have not been exercised by Thursday, 1 September 2022, or sold by Tuesday, 30 August 2022, will expire and become worthless. Holders of warrants of series TO 1 need to act and instruct their respective bank/nominee in advance before the last day of the exercise period. Note that the banks/nominees need to be notified well in advance before the exercise period ends.

An information document and subscription forms are available on the websites of CS MEDICA (www.cs-medica.com), Sedermera Corporate Finance AB (www.sedermera.se) and Nordic Issuing AB (www.nordic-issuing.se).

Advisors and issuing agent
Sedermera Corporate Finance AB is the financial advisor and Markets & Corporate Law Nordic AB is the legal advisor to CS MEDICA in connection with the warrant exercise. Nordic Issuing AB is the issuing agent.

For further information about the warrant exercise, please contact:
Sedermera Corporate Finance AB
Phone: +46 40 – 615 14 10
E-mail: cf@sedermera.se
www.sedermera.se

Nordic Issuing AB
Phone: +46 (0)40-632 00 20
E-mail: info@nordic-issuing.se
www.nordic-issuing.se

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@cs-medica.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.

Tags: